EYPT icon

EyePoint Pharmaceuticals

63 hedge funds and large institutions have $231M invested in EyePoint Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 7 closing their positions.

Holders
63
Holders Change
+3
Holders Change %
+5%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
20
Reduced
19
Closed
7
Calls
$3.74M
Puts
$835K
Net Calls
+$2.9M
Net Calls Change
+$278K
Name Market Value Shares Shares
Change
Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$38K 3,666 +1,471 +67%
Citigroup
52
Citigroup
New York
$25K 2,410 +1,404 +140%
Legal & General Group
53
Legal & General Group
United Kingdom
$18K 1,688 +1,688 New
AIP
54
Ameritas Investment Partners
Nebraska
$17K 1,657
LC
55
Lindbrook Capital
California
$10K 1,000 -4,500 -82%
UBS Group
56
UBS Group
Switzerland
$10K 1,016 -730 -42%
CMA
57
Cedar Mountain Advisors
Oregon
$10K 1,000
APA
58
American Portfolios Advisors
New York
$7.82K 750
TRCT
59
Tower Research Capital (TRC)
New York
$7K 682 -1,247 -65%
TC
60
Truvestments Capital
Florida
$3K 258
Osaic Holdings
61
Osaic Holdings
Arizona
$1K 48
GWM
62
Geneos Wealth Management
Colorado
$1K 100 +100 New
Group One Trading
63
Group One Trading
Illinois
-57,653 Closed
MWNA
64
Marshall Wace North America
New York
-55,325 Closed
Marshall Wace
65
Marshall Wace
United Kingdom
-37,746 Closed
BFM
66
Boothbay Fund Management
New York
-14,224 Closed
Wolverine Trading
67
Wolverine Trading
Illinois
-13,521 Closed
ECM
68
ExodusPoint Capital Management
New York
-13,400 Closed
PCM
69
Pinz Capital Management
New York
-6,222 Closed
CFGS
70
Concourse Financial Group Securities
Alabama
IA
71
IFP Advisors
Florida
CM
72
Caption Management
Oklahoma
Susquehanna International Group
73
Susquehanna International Group
Pennsylvania
Fidelity Investments
74
Fidelity Investments
Massachusetts
$0 4 +4 New